|
|
|
|
| Institutional Review Board (IRB) Application for Clinical Trial Skye 2028-3-001 | |
| IRB Application for Skye 2028-3-001 Clinical Trial, including application, amendments, correspondence, checklists, deviations/violations, and final approval | |
| Vital | |
Vital Records Protection Plan A
|
|
| Office of Research and Community Collaboration (ORCC) -- Institutional Review Board (IRB) Office | |
| Retain in the Institutional Review Board (IRB) Office until notified by MDS Pharma Services. "It is the responsibility of the sponsor [MDS Pharma Services] to inform the investigator [Marywood University] as to when clinical data/records no longer need to be retained" (Research & Financial Agreement, p.7). Then Marywood's IRB Office notifies other Marywood University offices that may have copies of the records. | |
Confidential Destruction: Destroy hard copies; delete electronic copies; destroy copies in other formats.
|
|
| Records may be retained as long as they are useful to the department until notified by Marywood's IRB Office. | |
Confidential Destruction: Destroy hard copies; delete electronic copies; destroy copies in other formats.
|
|
| Skye 2028-3-001 Clinical Trial contract | |
| MDS Pharma Services Research & Financial Agreement p.7 Director of Sponsored Projects, 03/10/2008 | |
| 03/12/2008, Director of Sponsored Projects |
|
Updated March 1, 2010 Maintained by James Sullivan, Director of Records Management and Archives © 2010 by Marywood University |
